Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 435916, 14 pages
http://dx.doi.org/10.1155/2013/435916
Research Article

4-Hydroxy-17-methylincisterol from Agaricus blazei Decreased Cytokine Production and Cell Proliferation in Human Peripheral Blood Mononuclear Cells via Inhibition of NF-AT and NF-B Activation

1National Research Institute of Chinese Medicine, No. 155-1, Section 2, Li-Nung Street, Shih-Pai 112, Taipei, Taiwan
2LS212, Laboratory of Molecular Pharmacology, Department of Life Science, Fu-Jen Catholic University, No. 510, Chung-Cheng Road, Hsinchuang 242, New Taipei, Taiwan
3Graduate School of Biotechnology, Hungkuang University, No. 34, Chung-Chie Road, Sha Lu 443, Taichung, Taiwan
4Department of Biotechnology and Laboratory Science in Medicine, School of Biomedical Science and Engineering, National Yang-Ming University, No. 155, Section 2, Li-Nung Street, Shih-Pai 112, Taipei, Taiwan

Received 26 September 2012; Revised 10 December 2012; Accepted 10 December 2012

Academic Editor: Juliano Ferreira

Copyright © 2013 Wei-Jern Tsai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Sorimachi, K. Akimoto, and T. Koge, “Inhibitory effect of Agaricu blazei murill components on abnormal collagen fiber formation in human hepatocarcinoma cells,” Bioscience, Biotechnology and Biochemistry, vol. 72, no. 2, pp. 621–623, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Higaki, F. Eguchi, and Y. Watanabe, “A stable culturing method and pharmacological effects of the Agaricus blazei,” Folia Pharmacologica Japonica, vol. 110, supplement 1, pp. 98–103, 1997. View at Google Scholar · View at Scopus
  3. F. Firenzuoli, L. Gori, and G. Lombardo, “The medicinal mushroom Agaricus blazei murrill: review of literature and pharmaco-toxicological problems,” Evidence-based Complementary and Alternative Medicine, vol. 5, no. 1, pp. 3–15, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Fujimiya, Y. Suzuki, K. I. Oshiman et al., “Selective tumoricidal effect of soluble proteoglucan extracted from the basidiomycete, Agaricus blazei Murill, mediated via natural killer cell activation and apoptosis,” Cancer Immunology Immunotherapy, vol. 46, no. 3, pp. 147–159, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Fujimiya, Y. Suzuki, R. Katakura, and T. Ebina, “Tumor-specific cytocidal and immunopotentiating effects of relatively low molecular weight products derived from the basidiomycete, Agaricus blazei Murill,” Anticancer Research, vol. 19, no. 1, pp. 113–118, 1999. View at Google Scholar · View at Scopus
  6. Y. Osaki, T. Kato, K. Yamamoto, J. Okubo, and T. Miyazaki, “Antimutagenic and bactericidal substances in the fruit body of a Basidiomycete Agaricus blazei, Jun-17,” Yakugaku Zasshi, vol. 114, no. 5, pp. 342–350, 1994. View at Google Scholar · View at Scopus
  7. L. Ziliotto, F. Pinheiro, L. F. Barbisan, and M. A. M. Rodrigues, “Screening for in vitro and in vivo antitumor activities of the mushroom Agaricus blazei,” Nutrition and Cancer, vol. 61, no. 2, pp. 245–250, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. C. Kuo, Y. L. Huang, C. C. Chen, Y. S. Lin, K. A. Chuang, and W. J. Tsai, “Cell cycle progression and cytokine gene expression of human peripheral blood mononuclear cells modulated by Agaricus blazei,” Journal of Laboratory and Clinical Medicine, vol. 140, no. 3, pp. 176–187, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. A. J. Charles Jr., T. Paul, S. Hunt, and M. Walport, Immunobiology, Current Biology, New York, NY, USA, 1997.
  10. R. P. Numerof and K. Asadullah, “Cytokine and anti-cytokine therapies for psoriasis and atopic dermatitis,” BioDrugs, vol. 20, no. 2, pp. 93–103, 2006. View at Google Scholar · View at Scopus
  11. K. Arai, F. Lee, A. Miyajima, S. Miyatake, N. Arai, and T. Yokota, “Cytokines: coordinators of immune and inflammatory responses,” Annual Review of Biochemistry, vol. 59, pp. 783–836, 1990. View at Google Scholar · View at Scopus
  12. D. Cantrell, “T cell antigen receptor signal transduction pathways,” Annual Review of Immunology, vol. 14, pp. 259–274, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Rao, C. Luo, and P. G. Hogan, “Transcription factors of the NFAT family: regulation and function,” Annual Review of Immunology, vol. 15, pp. 707–747, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. J. A. DiDonato, F. Mercurio, and M. Karin, “NF-kB and the link between inflammation and cancer,” Immunology Review, vol. 246, no. 1, pp. 379–400, 2012. View at Google Scholar
  15. M. J. Kwon, R. Wang, J. Ma, and Z. Sun, “PKC-θ is a drug target for prevention of T cell-mediated autoimmunity and allograft rejection,” Endocrine, Metabolic & Immune Disorders Drug Targets, vol. 10, no. 4, pp. 367–372, 2010. View at Google Scholar · View at Scopus
  16. Y. C. Chen, W. J. Tsai, M. H. Wu, L. C. Lin, and Y. C. Kuo, “Suberosin inhibits proliferation of human peripheral blood mononuclear cells through the modulation of the transcription factors NF-AT and NF-κB,” British Journal of Pharmacology, vol. 150, no. 3, pp. 298–312, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. M. H. Wu, W. J. Tsai, M. J. Don, Y. C. Chen, I. S. Chen, and Y. C. Kuo, “Tanshinlactone A from Salvia miltiorrhiza modulates interleukin-2 and interferon-γ gene expression,” Journal of Ethnopharmacology, vol. 113, no. 2, pp. 210–217, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Chen, Z. Li, L. Bai, and Y. Lin, “NF-κB in lung cancer, a carcinogenesis mediator and a prevention and therapy target,” Frontiers in Bioscience, vol. 16, no. 3, pp. 1172–1185, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Y. Donath and S. E. Shoelson, “Type 2 diabetes as an inflammatory disease,” Nature Reviews Immunology, vol. 11, no. 2, pp. 98–107, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. J. S. Kennedy, M. Raab, and C. E. Rudd, “Signaling scaffolds in immune cells,” Cell Calcium, vol. 26, no. 5, pp. 227–235, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. A. L. Sica, L. Dorman, V. Viggiano et al., “Interaction of NF-κB and NFAT with the interferon-γ promoter,” Journal of Biological Chemistry, vol. 272, no. 48, pp. 30412–30420, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Dong, R. J. Davis, and R. A. Flavell, “MAP kinases in the immune response,” Annual Review of Immunology, vol. 20, pp. 55–72, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. F. J. Dumont, M. J. Staruch, P. Fischer, C. DaSilva, and R. Camacho, “Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production,” Journal of Immunology, vol. 160, no. 6, pp. 2579–2589, 1998. View at Google Scholar · View at Scopus
  24. M. Arnaud, C. Crouin, C. Deon, D. Loyaux, and J. Bertoglio, “Phosphorylation of Grb2-associated binder 2 on serine 623 by ERK MAPK regulates its association with the phosphatase SHP-2 and decreases STAT5 activation,” Journal of Immunology, vol. 173, no. 6, pp. 3962–3971, 2004. View at Google Scholar · View at Scopus
  25. A. E. Schade and A. D. Levine, “Cutting edge: extracellular signal-regulated kinases 1/2 function as integrators of TCR signal strength,” Journal of Immunology, vol. 172, no. 10, pp. 5828–5832, 2004. View at Google Scholar · View at Scopus
  26. C. P. Liu, W. J. Tsai, Y. L. Lin, J. F. Liao, C. F. Chen, and Y. C. Kuo, “The extracts from Nelumbo nucifera suppress cell cycle progression, cytokine genes expression, and cell proliferation in human peripheral blood mononuclear cells,” Life Sciences, vol. 75, no. 6, pp. 699–716, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Togashi, Y. Mizushina, M. Takemura et al., “4-hydroxy-17-methylincisterol, an inhibitor of DNA polymerase-α activity and the growth of human cancer cells in vitro,” Biochemical Pharmacology, vol. 56, no. 5, pp. 583–590, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. C. Kuo, N. S. Yang, C. J. Chou, L. C. Lin, and W. J. Tsai, “Regulation of cell proliferation, gene expression, production of cytokines, and cell cycle progression in primary human T lymphocytes by piperlactam S isolated from Piper kadsura,” Molecular Pharmacology, vol. 58, no. 5, pp. 1057–1066, 2000. View at Google Scholar · View at Scopus
  29. Y. C. Kuo, S. C. Weng, C. J. Chou, T. T. Chang, and W. J. Tsai, “Activation and proliferation signals in primary human T lymphocytes inhibited by ergosterol peroxide isolated from Cordyceps cicadae,” British Journal of Pharmacology, vol. 140, no. 5, pp. 895–906, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Taniguchi, H. Matsui, and T. Fujita, “Structure and expression of a cloned cDNA for human interleukin-2,” Nature, vol. 302, no. 5906, pp. 305–310, 1983. View at Google Scholar · View at Scopus
  31. P. W. Gray, D. W. Leung, and D. Pennica, “Expression of human immune interferon cDNA in Polygonum hypoleucum and monkey cells,” Nature, vol. 295, no. 5849, pp. 503–508, 1982. View at Google Scholar · View at Scopus
  32. T. Yokota, T. Otsuka, and T. Mosmann, “Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities,” Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 16, pp. 5894–5898, 1986. View at Google Scholar · View at Scopus
  33. Y. C. Kuo, W. J. Tsai, H. C. Meng, W. P. Chen, L. Y. Yang, and C. Y. Lin, “Immune reponses in human mesangial cells regulated: by emodin from Polygonum hypoleucum Ohwi,” Life Sciences, vol. 68, no. 11, pp. 1271–1286, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. A. G. S. Buggins, D. Milojkovic, M. J. Arno et al., “Microenvironment produced by acute myeloid leukemia cells prevents T cell activation and proliferation by inhibition of NF-κb, c-Myc, and pRb pathways,” Journal of Immunology, vol. 167, no. 10, pp. 6021–6030, 2001. View at Google Scholar · View at Scopus
  35. L. L. Carter, X. Zhang, C. Dubey, P. Rogers, L. Tsui, and S. L. Swain, “Regulation of T cell subsets from naive to memory,” Journal of Immunotherapy, vol. 21, no. 3, pp. 181–187, 1998. View at Google Scholar · View at Scopus
  36. C. P. Liu, Y. C. Kuo, C. C. Shen et al., “(S)-armepavine inhibits human peripheral blood mononuclear cell activation by regulating Itk and PLCγ activation in a PI-3K-dependent manner,” Journal of Leukocyte Biology, vol. 81, no. 5, pp. 1276–1286, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Francesco, S. Aldo, I. Irene, G. Assunta, and S. Guido, “Synthesis of (17R)-17-methylincisterol, a highly degraded marine steroid,” Tetrahedron Letters, vol. 36, no. 24, pp. 4303–4306, 1995. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Ajchenbaum, K. Ando, J. A. DeCaprio, and J. D. Griffin, “Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes,” Journal of Biological Chemistry, vol. 268, no. 6, pp. 4113–4119, 1993. View at Google Scholar · View at Scopus
  39. N. Y. Tang, J. S. Yang, J. P. Lin et al., “Effects of Agaricus blazei murill extract on immune responses in normal BALB/c mice,” In Vivo, vol. 23, no. 5, pp. 761–766, 2009. View at Google Scholar · View at Scopus
  40. H. Yoshida, H. Nishina, H. Takimoto et al., “The transcription factor NF-ATc1 regulates lymphocyte proliferation and Th2 cytokine production,” Immunity, vol. 8, no. 1, pp. 115–124, 1998. View at Publisher · View at Google Scholar · View at Scopus
  41. V. Ferreira, N. Sidénius, N. Tarantino et al., “In vivo inhibition of NF-κB in T-lineage cells leads to a dramatic decrease in cell proliferation and cytokine production and to increased cell apoptosis in response to mitogenic stimuli, but not to abnormal thymopoiesis,” Journal of Immunology, vol. 162, no. 11, pp. 6442–6450, 1999. View at Google Scholar · View at Scopus
  42. H. J. Lee, I. Matsuda, Y. Naito, T. Yokota, N. Arai, and K. I. Arai, “Signals and nuclear factors that regulate the expression of interleukin-4 and interleukin-5 genes in helper T cells,” Journal of Allergy and Clinical Immunology, vol. 94, no. 3, pp. 594–604, 1994. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Vallabhapurapu and M. Karin, “Regulation and function of NF-κB transcription factors in the immune system,” Annual Review of Immunology, vol. 27, pp. 693–733, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. V. Sée, N. K. M. Rajala, D. G. Spiller, and M. R. H. White, “Calcium-dependent regulation of the cell cycle via a novel MAPK-NF-κB pathway in Swiss 3T3 cells,” Journal of Cell Biology, vol. 166, no. 5, pp. 661–672, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. R. S. Lewis, “Calcium signaling mechanisms in T lymphocytes,” Annual Review of Immunology, vol. 19, pp. 497–521, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. E. Díaz-Flores, M. Siliceo, C. Martinez-A. C., and I. Mérida, “Membrane translocation of protein kinase Cθ during T lymphocyte activation requires phospholipase C-γ-generated diacylglycerol,” Journal of Biological Chemistry, vol. 278, no. 31, pp. 29208–29215, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. N. M. Steffan, G. D. Bren, B. Frantz, M. J. Tocci, E. A. O'Neill, and C. V. Paya, “Regulation of IkBα phosphorylation by PKC- and Ca2+-dependent signal transduction pathways,” Journal of Immunology, vol. 155, no. 10, pp. 4685–4691, 1995. View at Google Scholar · View at Scopus
  48. D. H. Boschelli, “Small molecule inhibitors of PKCθ as potential antiinflammatory therapeutics,” Current Topics in Medicinal Chemistry, vol. 9, no. 7, pp. 640–654, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. S. L. Schreiber and G. R. Crabtree, “The mechanism of action of cyclosporin A and FK506,” Immunology Today, vol. 13, no. 4, pp. 136–142, 1992. View at Google Scholar · View at Scopus
  50. C. Norbury and P. Nurse, “Animal cell cycles and their control,” Annual Review of Biochemistry, vol. 61, pp. 441–470, 1992. View at Google Scholar · View at Scopus
  51. R. B. Goodman, R. M. Strieter, D. P. Martin et al., “Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome,” American Journal of Respiratory and Critical Care Medicine, vol. 154, no. 3 I, pp. 602–611, 1996. View at Google Scholar · View at Scopus
  52. M. F. Neurath, S. Pettersson, K. H. Meyer Zum Buschenfelde, and W. Strober, “Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice,” Nature Medicine, vol. 2, no. 9, pp. 998–1004, 1996. View at Publisher · View at Google Scholar · View at Scopus
  53. N. A. Hanania, “Targeting airway inflammation in asthma: current and future therapies,” Chest, vol. 133, no. 4, pp. 989–998, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. C. H. Hsu, K. C. Hwang, Y. H. Chiang, and P. Chou, “The mushroom Agaricus blazei Murill extract normalizes liver function in patients with chronic hepatitis B,” Journal of Alternative and Complementary Medicine, vol. 14, no. 3, pp. 299–301, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. M. M. Padilha, A. A. L. Avila, P. J. C. Sousa, L. G. V. Cardoso, F. F. Perazzo, and J. C. T. Carvalho, “Anti-inflammatory activity of aqueous and alkaline extracts from mushrooms (Agaricus blazei Murill),” Journal of Medicinal Food, vol. 12, no. 2, pp. 359–364, 2009. View at Publisher · View at Google Scholar · View at Scopus